Exact Mass: 371.1345

Exact Mass Matches: 371.1345

Found 166 metabolites which its exact mass value is equals to given mass value 371.1345, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Methyl-14-O-demethylepiporphyroxine

17-methoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14,16,18-hexaene-11,16-diol

C20H21NO6 (371.1369)

N-Methyl-14-O-demethylepiporphyroxine is an alkaloid from Papaver somniferum (opium poppy

4-(1-Isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine

N-(4-methanesulfonylphenyl)-4-[2-methyl-1-(propan-2-yl)-1H-imidazol-5-yl]pyrimidin-2-amine

C18H21N5O2S (371.1416)

Amocarzine

4-methyl-N-{4-[(4-nitrophenyl)amino]phenyl}piperazine-1-carbothioamide

C18H21N5O2S (371.1416)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

2-[4-[(2,5-Difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline

2-(4-((2,5-Difluorophenyl)methoxy)phenoxy)-5-ethoxyaniline

C21H19F2NO3 (371.1333)

(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide

(3Z)-N,N-Dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-2,3-dihydro-1H-indole-5-sulphonamide

C19H21N3O3S (371.1304)

AZD5438

4-(1-Isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine

C18H21N5O2S (371.1416)

2-Demethyl-colchicein

C20H21NO6 (371.1369)

N-(3-hydroxy-1,2,10-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)formamide

C20H21NO6 (371.1369)

(7S)-6-methoxy-2-methyl-6,8,3,4-tetrahydro-2H-(7rN)-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-6t,8t,7-triol|ledeboridine|Ledebouridin|ledebouridine

C20H21NO6 (371.1369)

Andesine

C20H21NO6 (371.1369)

Chiloenine

C20H21NO6 (371.1369)

2-Demethylcolchicein|2-Desmethylcolchicein|3-Demethyl-colchicein

C20H21NO6 (371.1369)

Cryptopleurospermin|Cryptopleurospermine|[6-(2-dimethylamino-ethyl)-benzo[1,3]dioxol-5-yl]-(3-hydroxy-4-methoxy-phenyl)-ethanedione

C20H21NO6 (371.1369)

Grossularine 2

C21H17N5O2 (371.1382)

CHEMBL1668601

C20H21NO6 (371.1369)

NSC180532

C20H21NO6 (371.1369)

5,6-dimethoxy-2-(2,5,6-trimethoxyphenyl)-1h-quinolin-4-one

C20H21NO6 (371.1369)

2-Demethyl-N-deacetyl-N-formylcolchicine|2-Demethyl-N-formyl-N-desacetyl-colchicin

C20H21NO6 (371.1369)

NSC354974

C20H21NO6 (371.1369)

(-)-8-oxo-2,10-dihydroxy-3,9,11-trimethoxyberberine

C20H21NO6 (371.1369)

CHEMBL1668602

C20H21NO6 (371.1369)

C20H21NO6

C20H21NO6 (371.1369)

(-)-(S)-O-acetylevodine

C20H21NO6 (371.1369)

Trigonostemine B

C22H17N3O3 (371.127)

(+)-N-methoxycarbonyl-lindcarpine

C20H21NO6 (371.1369)

7-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-L-glycero-alpha-D-manno-heptopyranoside

C13H25NO11 (371.1428)

Ser Glu His

C14H21N5O7 (371.1441)

Thr Asp His

C14H21N5O7 (371.1441)

Asp His Thr

C14H21N5O7 (371.1441)

Glu Ser His

C14H21N5O7 (371.1441)

Ser His Glu

C14H21N5O7 (371.1441)

His Asp Thr

C14H21N5O7 (371.1441)

Thr His Asp

C14H21N5O7 (371.1441)

Asp Thr His

C14H21N5O7 (371.1441)

ACMC-20mkrd

C14H21N5O7 (371.1441)

His Thr Asp

C14H21N5O7 (371.1441)

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-1H-indole-5-sulfonamide

C19H21N3O3S (371.1304)

Naratriptan HCl

C17H26ClN3O2S (371.1434)

C20H21NO6_6-Methoxy-2-methyl-3,4,6,8-tetrahydro-2H-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-7,8-diol 2-oxide

NCGC00385471-01_C20H21NO6_6-Methoxy-2-methyl-3,4,6,8-tetrahydro-2H-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-7,8-diol 2-oxide

C20H21NO6 (371.1369)

MMV676604

C18H21N5O2S (371.1416)

Lycorine-diacetate

C20H21NO6 (371.1369)

[Raw Data] CBA62_Lycorine-2Ac_pos_50eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_40eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_30eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_20eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_10eV.txt

Duguetine N-oxide

C20H21NO6 (371.1369)

Duguetine ??-N-oxide

C20H21NO6 (371.1369)

His Ser Glu

C14H21N5O7 (371.1441)

Glu His Ser

C14H21N5O7 (371.1441)

His Glu Ser

C14H21N5O7 (371.1441)

SU 6656

2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide

C19H21N3O3S (371.1304)

SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.

Alkaloid a4

17-methoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0^{2,10}.0^{5,9}.0^{14,19}]docosa-2,4,9,14,16,18-hexaene-11,16-diol

C20H21NO6 (371.1369)

Levobunolol sulfate

C17H25NO6S (371.1403)

chelidonine monohydrate*

C20H21NO6 (371.1369)

ONO-RS-082

C21H22ClNO3 (371.1288)

ONO-RS-082 is an inhibitor of phospholipase A (PLA)[1]. ONO-RS-082 inhibits PLA2 with the IC50 of 1.0 μM, but does not inhibit PLC even at 100 μM[2].

Urea, N-[(2-chloro-7,8-dimethyl-3-quinolinyl)methyl]-N-(2-furanylmethyl)-N,N-dimethyl- (9CI)

C20H22ClN3O2 (371.14)

Urea, N-[(2-chloro-6,7-dimethyl-3-quinolinyl)methyl]-N-(2-furanylmethyl)-N,N-dimethyl- (9CI)

C20H22ClN3O2 (371.14)

Naratriptan Hydrochloride

C17H26ClN3O2S (371.1434)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Naratriptan hydrochloride is a selective 5-HT1 receptor subtype agonist and is a triptan drug that is used for the treatment of migraine headaches. Target: 5-HT1 Receptor Naratriptan is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. Naratriptan is available in 2.5 mg tablets. It is a selective 5-HT1 receptor subtype agonist. Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migraine, including severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light. The causes of migraine are not clearly understood; however, the efficacy of naratriptans and other triptans is believed to be due to their activity as 5HT (serotonin) agonists.A meta-analysis of 53 clinical trials has shown that all triptans are effective for treating migraine at marketed doses and that naratriptan, although less effective than sumatriptan and rizatriptan was more effective than placebo in reducing migraine symptoms at two hours and efficacy was demonstrated in almost two thirds of subjects after four hours of treatment.

Z-Glu-OBzl

C20H21NO6 (371.1369)

Z-Glu(OBzl)-OH

C20H21NO6 (371.1369)

N-Cbz-D-glutamic acid α-benzyl ester

C20H21NO6 (371.1369)

Tubastatin A HCl

C20H22ClN3O2 (371.14)

SEA-0400

2-(4-((2,5-Difluorobenzyl)oxy)phenoxy)-5-ethoxyaniline

C21H19F2NO3 (371.1333)

Z-D-Glu(OBzl)-OH

C20H21NO6 (371.1369)

7-HYDROXY-8-((2-METHOXYPHENYL)DIAZENYL)-N,N,N-TRIMETHYLNAPHTHALEN-2-AMINIUM CHLORIDE

C20H22ClN3O2 (371.14)

(S)-4-tert-butoxycarbonyl-2-p-toluenesulfonyloxymethylmorpholine

C17H25NO6S (371.1403)

1,5-Naphthyridine-3-carboxamide, 7-((4-fluorophenyl)methyl)-1,2-dihydro-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-

C19H18FN3O4 (371.1281)

SU6656

(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide

C19H21N3O3S (371.1304)

[5-Amino-1-(4-fluorophenyl)-1H-pyrazol-4-YL](3-{[(2R)-2,3-dihydroxypropyl]oxy}phenyl)methanone

C19H18FN3O4 (371.1281)

1-[1-oxo-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]ethyl]-4-piperidinecarboxylic acid

C20H21NO6 (371.1369)

N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide

C19H21N3O3S (371.1304)

His-Ser-Glu

C14H21N5O7 (371.1441)

(R)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

C19H21N3O3S (371.1304)

(S)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

C19H21N3O3S (371.1304)

N-[2-(1H-Indol-5-YL)-butyl]-4-sulfamoyl-benzamide

C19H21N3O3S (371.1304)

(+)-N-(methoxycarbonyl)-N-norboldine

C20H21NO6 (371.1369)

An aporphine alkaloid that is laurolistine with a N-methoxycarbonyl group. Isolated from the aerial parts of Litsea cubeba, it exhibits antimicrobial activities.

4-hydroxy-1-(3-methylbutyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydroquinoline-3-carboxamide

C19H21N3O3S (371.1304)

5-(2,3-Dihydroindol-1-ylsulfonyl)-1,3-diethyl-2-benzimidazolone

C19H21N3O3S (371.1304)

[4-[[4-(Methylthio)phenyl]methyl]-1-piperazinyl]-(4-nitrophenyl)methanone

C19H21N3O3S (371.1304)

3-Methyl-1-phenyl-5-thieno[2,3-c]pyrazolecarboxylic acid [2-(butylamino)-2-oxoethyl] ester

C19H21N3O3S (371.1304)

5-(dimethylamino)-N-[4-(hydroxyamino)benzyl]naphthalene-1-sulfonamide

C19H21N3O3S (371.1304)

Asp-Thr-His

C14H21N5O7 (371.1441)

His-Asp-Thr

C14H21N5O7 (371.1441)

Ser-Glu-His

C14H21N5O7 (371.1441)

Ser-His-Glu

C14H21N5O7 (371.1441)

Asp-His-Thr

C14H21N5O7 (371.1441)

Glu-His-Ser

C14H21N5O7 (371.1441)

hydron;N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide;chloride

C17H26ClN3O2S (371.1434)

Thr-His-Asp

C14H21N5O7 (371.1441)

His-Thr-Asp

C14H21N5O7 (371.1441)

Glu-Ser-His

C14H21N5O7 (371.1441)

His-Glu-Ser

C14H21N5O7 (371.1441)

Thr-Asp-His

C14H21N5O7 (371.1441)

1,2-Diacetoxylycorine

C20H21NO6 (371.1369)

2-Amino-3-[(3-heptanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C13H26NO9P (371.1345)

(11S,12S,13S)-16,17-dimethoxy-11-methyl-11-oxido-3,5-dioxa-11-azoniapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

C20H21NO6 (371.1369)

(11R,12S,13S)-16,17-dimethoxy-11-methyl-11-oxido-3,5-dioxa-11-azoniapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

C20H21NO6 (371.1369)

9,11-Diphenylbenzo(E)pyrimido(4,5-B)indole

C26H17N3 (371.1422)

Amocarzine

C18H21N5O2S (371.1416)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

N-Methyl-14-O-demethylepiporphyroxine

C20H21NO6 (371.1369)

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)indoline-5-sulfonamide

C19H21N3O3S (371.1304)

LPC 5:1;O2

C13H26NO9P (371.1345)

LPE 8:1;O2

C13H26NO9P (371.1345)

VUF-5574

C21H17N5O2 (371.1382)

VUF-5574 is a selective antagonist of adenosine A3 receptor with a Ki of 4.03 nM for the recombinant human receptor[1].

(1r)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol

C20H21NO6 (371.1369)

n-{5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}carboximidic acid

C20H21NO6 (371.1369)

13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate

C20H21NO6 (371.1369)

n-[(10s)-4-hydroxy-3,5,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]carboximidic acid

C20H21NO6 (371.1369)

n-[(10s,12r,16s)-5-hydroxy-3,4,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl]carboximidic acid

C20H21NO6 (371.1369)

(2s)-4,9-dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2h,3h-furo[3,2-b]acridin-5-one

C20H21NO6 (371.1369)

(2s)-n-{6-[(r)-(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-2-methylbutanimidic acid

C20H21NO6 (371.1369)

(2e)-4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methylbut-2-en-1-yl acetate

C20H21NO6 (371.1369)

6-methoxy-3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole

C22H17N3O3 (371.127)

16-oxodelavaine

C20H21NO6 (371.1369)

{"Ingredient_id": "HBIN001942","Ingredient_name": "16-oxodelavaine","Alias": "NA","Ingredient_formula": "C20H21NO6","Ingredient_Smile": "CN1C2CC3=CC4=C(C=C3C5(C2C(=C(C(=O)C5)OC)OC)CC1=O)OCO4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16299","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}